Despite a decline in incidence and mortality during the last decades, stomach cancer is one
of the main health challenges worldwide. According to the GLOBOCAN 2020 estimates …

Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …

More than 1 million (1 089 103) new cases of gastric cancer were estimated globally in
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …

Importance Gastric cancer is one of the most common cancers, with a high mortality-to-
incidence ratio. It is uncertain whether developed nations may encounter an increasing …

Background & Aims There were an estimated 4.8 million new cases of gastrointestinal (GI)
cancers and 3.4 million related deaths, worldwide, in 2018. GI cancers account for 26% of …

Background Synthesised data on the prevalence of, and factors associated with, paediatric
Helicobacter pylori infection at the global level remain scarce. We aimed to estimate the …

Gastric cancer (GC) is a leading contributor to global cancer incidence and mortality.
Pioneering genomic studies, focusing largely on primary GCs, revealed driver alterations in …

Mesenchymal stromal cells (MSCs) are a subset of heterogeneous non-hematopoietic
fibroblast-like cells that can differentiate into cells of multiple lineages, such as …

Objectives The incidence of gastric cancer continues to decrease globally, approaching
levels that in some populations could define it as a rare disease. To explore this on a wider …